Evaluating the molecular mechanisms of the therapeutic effects of Cynata-MSCs in a murine model of pulmonary fibrosis

Project: Research

Project Details

Project Description

This is a contract research agreement between Monash University and Cynata Therapeutics Ltd (Carlton South, VIC) for Prof. Chrishan Samuel (Monash Pharmacology) to evaluate the molecular mechanisms of Cynata-MSCs (stem cells developed by Cynata) in a mouse model of bleomycin-induced pulmonary fibrosis.
*The fully executed agreement has been attached.
Short titleMolecular mechanisms of Cynata-MSCs in pulmonary fibrosis
Effective start/end date11/02/2130/09/21


  • Cynata Therapeutics Ltd: AUD166,736.00


  • Pulmonary Fibrosis
  • iPSCs-derived mesenchymal stem cells
  • Fibrosis
  • Mechanisms of action